| scholarly article | Q13442814 |
| P50 | author | Evangelia Tsolaki | Q87712663 |
| P2093 | author name string | Anil K Saxena | |
| Athina Geronikaki | |||
| Phaedra Eleftheriou | |||
| Victor Kartsev | |||
| P2860 | cites work | The structure of human 5-lipoxygenase | Q24337021 |
| The role of lipoxygenases in pathophysiology; new insights and future perspectives | Q26795652 | ||
| Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 A reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead | Q27641999 | ||
| The 1.85 Å Structure of an 8 R -Lipoxygenase Suggests a General Model for Lipoxygenase Product Specificity | Q27646536 | ||
| Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663 | Q27678617 | ||
| Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock | Q27702054 | ||
| Crystal structure of soybean lipoxygenase L-1 at 1.4 A resolution | Q27733249 | ||
| The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity | Q27748747 | ||
| Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets | Q27902293 | ||
| The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma | Q84981001 | ||
| Synthesis and SAR study of 4,5-diaryl-1H-imidazole-2(3H)-thione derivatives, as potent 15-lipoxygenase inhibitors | Q85333641 | ||
| Inhibitory activity of salicylic acid on lipoxygenase-dependent lipid peroxidation. | Q46297603 | ||
| Development of novel peptide inhibitor of Lipoxygenase based on biochemical and BIAcore evidences. | Q46437194 | ||
| Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition | Q46724646 | ||
| Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH. | Q46907322 | ||
| Human colorectal cancer progression correlates with LOX-induced ECM stiffening | Q47136357 | ||
| Docking assisted design of novel 4-adamantanyl-2-thiazolylimino-5-arylidene-4-thiazolidinones as potent NSAIDs | Q47211137 | ||
| Docking analysis targeted to the whole enzyme: an application to the prediction of inhibition of PTP1B by thiomorpholine and thiazolyl derivatives. | Q47559246 | ||
| Prediction of enzyme inhibition and mode of inhibitory action based on calculation of distances between hydrogen bond donor/acceptor groups of the molecule and docking analysis: An application on the discovery of novel effective PTP1B inhibitors. | Q50853981 | ||
| The pharmacokinetics of zileuton in healthy young and elderly volunteers. | Q51034430 | ||
| Computational insight into the catalytic implication of head/tail-first orientation of arachidonic acid in human 5-lipoxygenase: consequences for the positional specificity of oxygenation. | Q51595757 | ||
| Imidazo[2,1-b]thiazole derivatives as new inhibitors of 15-lipoxygenase. | Q54481955 | ||
| Designing, synthesis of selective and high-affinity chalcone-benzothiazole hybrids as Brugia malayi thymidylate kinase inhibitors: In vitro validation and docking studies. | Q55042641 | ||
| Synthesis and structure-activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridine-alkanoic acids and 4-(2-carboxyphenyl)aminobenzenealkanoic acids | Q67283371 | ||
| Leukotriene B4: An inflammatory mediator In vivo | Q72910129 | ||
| Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis | Q28167018 | ||
| The role of leukotrienes in allergic diseases | Q28255154 | ||
| 5-lipoxygenase: a promising drug target against inflammatory diseases-biochemical and pharmacological regulation | Q28303461 | ||
| 2-ABT-S-oxide detoxification by glutathione S-transferases A1-1, M1-1 and P1-1: implications for toxicity associated with zileuton | Q30448005 | ||
| Mycophenolic acid in the treatment of psoriasis: long-term administration | Q33496833 | ||
| Role of Leukotrienes and Leukotriene Modifiers in Asthma | Q33664150 | ||
| LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. | Q34079451 | ||
| Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update | Q34081291 | ||
| Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors | Q34084156 | ||
| Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. | Q34138303 | ||
| Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis | Q34349369 | ||
| MolDock: a new technique for high-accuracy molecular docking | Q34530159 | ||
| Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications | Q34997971 | ||
| Lipoxygenase pathways in atherogenesis | Q35840304 | ||
| Designed multiple ligands. An emerging drug discovery paradigm | Q36284452 | ||
| Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach | Q36477542 | ||
| 5-lipoxygenase: regulation and possible involvement in atherosclerosis | Q36811675 | ||
| Control of oxygenation in lipoxygenase and cyclooxygenase catalysis | Q36831450 | ||
| Lipoxygenase: an emerging target for stroke therapy | Q36913914 | ||
| Licofelone: the answer to unmet needs in osteoarthritis therapy? | Q37154867 | ||
| 5-Lipoxygenase: mechanisms of regulation | Q37173201 | ||
| Roles of Eicosanoids in Prostate Cancer | Q37592857 | ||
| LOX-1: a new target for therapy for cardiovascular diseases | Q37914024 | ||
| Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome. | Q38375421 | ||
| 15-Lipoxygenase inhibitors: a patent review | Q38631240 | ||
| The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease. | Q38671719 | ||
| Synthesis and biological activity of mycophenolic acid-amino acid derivatives. | Q39079816 | ||
| Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors. | Q39382602 | ||
| Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety | Q39717156 | ||
| Reciprocal regulation of 12- and 15-lipoxygenases by UV-irradiation in human keratinocytes | Q39946085 | ||
| Phospholipid Methylation and Biological Signal Transmission | Q40098375 | ||
| Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain | Q43105677 | ||
| Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach | Q43974012 | ||
| Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. | Q44068950 | ||
| Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets | Q44648420 | ||
| Enteric-coated mycophenolate sodium in psoriasis vulgaris: an open pilot study. | Q45860651 | ||
| Synthesis of 4-benzyl-1,3-thiazole derivatives as potential anti-inflammatory agents: an analogue-based drug design approach. | Q45996393 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P577 | publication date | 2018-07-03 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Application of Docking Analysis in the Prediction and Biological Evaluation of the Lipoxygenase Inhibitory Action of Thiazolyl Derivatives of Mycophenolic Acid | |
| P478 | volume | 23 |
Search more.